Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risperidone, quantity: 1 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; magnesium stearate; hypromellose; maize starch; microcrystalline cellulose; propylene glycol; lactose monohydrate; purified talc; colloidal anhydrous silica - treatment of schizophrenia and related psychoses. . short term treatment of acute mania associated with bipolar 1 disorder. . treatment of behavioural disturbances in dementia. . treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. . treatment of behavioural disorders associated with autism in children and adolescents.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risperidone, quantity: 4 mg - tablet, film coated - excipient ingredients: maize starch; microcrystalline cellulose; quinoline yellow aluminium lake; propylene glycol; purified talc; indigo carmine aluminium lake; colloidal anhydrous silica; lactose monohydrate; sodium lauryl sulfate; titanium dioxide; hypromellose; magnesium stearate - treatment of schizophrenia and related psychoses. . short term treatment of acute mania associated with bipolar 1 disorder. . treatment of behavioural disturbances in dementia. . treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. . treatment of behavioural disorders associated with autism in children and adolescents.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - risperidone, quantity: 3 mg - tablet, film coated - excipient ingredients: titanium dioxide; sodium lauryl sulfate; microcrystalline cellulose; colloidal anhydrous silica; lactose monohydrate; purified talc; magnesium stearate; quinoline yellow aluminium lake; hypromellose; propylene glycol; maize starch - treatment of schizophrenia and related psychoses. . short term treatment of acute mania associated with bipolar 1 disorder. . treatment of behavioural disturbances in dementia. . treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. . treatment of behavioural disorders associated with autism in children and adolescents.

United States - English - NLM (National Library of Medicine)

seroyal usa - apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z) - apis mellifera 1 [hp_x] - indications for the temporary relief of allergic symptoms indications for the temporary relief of allergic symptoms directions adults: take five granules three times daily or as recommended by your healthcare practitioner. children: take three granules and follow adult directions.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - prochlorperazine maleate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; purified water; colloidal anhydrous silica; magnesium stearate - nausea and vomiting due to various causes including migraine; vertigo due to meniere's syndrome, labyrinthitis and other causes.

United States - English - NLM (National Library of Medicine)

standard homeopathic company - apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z) - apis mellifera 30 [hp_x] in 1 g - bites, stings or swellings

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mirtazapine, quantity: 45 mg - tablet, film coated - excipient ingredients: hypromellose; croscarmellose sodium; macrogol 8000; hyprolose; microcrystalline cellulose; titanium dioxide; magnesium stearate; lactose monohydrate - treatment of major depression including relapse prevention

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mirtazapine, quantity: 30 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; titanium dioxide; croscarmellose sodium; magnesium stearate; macrogol 8000; iron oxide red; iron oxide yellow; hyprolose; lactose monohydrate - treatment of major depression including relapse prevention

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mirtazapine, quantity: 15 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; iron oxide yellow; hypromellose; titanium dioxide; macrogol 8000; magnesium stearate; lactose monohydrate; hyprolose; microcrystalline cellulose - treatment of major depression including relapse prevention

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 111.92 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; peg-150 distearate; lauromacrogol 400 - children and adolescents sertraline hydrochloride is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults sertraline hydrochloride is indicated for: the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. sertraline hydrochloride is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. sertraline hydrochloride is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.